NewsRx

Search our medical news database

Cancer Weekly

Susan Hasty, Publisher

Table of Contents . . . July 26th, 1999

Non-Subscriber - Summaries Only

Related Areas: Other Issues in Cancer Weekly | Other Publications

Medicinal Marijuana - Canada Gives Two Patients Go-Ahead To Smoke Marijuana

Pediatrics - Girl with Brain Tumor Finds Hope Through "Healing the Children"

Anti-Angiogenesis Therapy - "Phase I Dose-Escalating Trial of SU5416, a Novel Angiogenesis Inhibitor in Patients with Advanced Malignancies."

Antisense Therapy - "Phase I Trial of a Second Generation Oligonucleotide (GEM 231) Targeted at Type I Protein Kinase A In Patients With Refractory Solid Tumors."

Cancer Gene Therapy - "A Retroviral Tetracycline (TET) Regulated System for in vivo Manipulation of IL-2 Expression."

Cancer Immunotherapy - "Phagocytes from Long-Term Survivor Renal Cell Carcinoma and Melanoma Patients Fail to Secrete IL-10 When Challenged With Tumor Apoptotic Cells."

Cancer Vaccines - "Clinical Activity and Broken Immunologic Tolerance from ex vivo GM-CSF Gene Transduced Prostate Cancer Vaccines."

Cancer Vaccines - "Polynucleotide Vaccines for Colon Cancer and Melanoma."

Cancer Vaccines - "The Role of Heat Shock Proteins for Vaccination Models in Renal Cell Carcinoma."

Pathogenesis (Angiogenesis) - "Vascular Endothelial Growth Factor Is Transcriptionally Regulated by Cell Density in Prostate Cancer Cells."

Prognostic Factors (Cancer) - "Increased Angiogenin Expression in the Tumor Tissue and Serum in Urotherial Cancer Patients Is Related to Disease Progression and Recurrence."

Antisense Technology - "Antisense Oligonucleotides to Class III beta-Tubulin Sensitize Drug-Resistant Cells to Taxol."

Cancer Immunology - "The Tumorigenicity of IL-2 Gene-Transfected Murine M-3D Melanoma Cells Is Determined by the Magnitude and Quality of the Host Defense Reaction: NK Cells Play a Major Role."

Cancer Immunotherapy - "Therapeutic Effects of Tumor-Reactive Type 1 and Type 2 CD8+ T-Cell Subpopulations in Established Pulmonary Metastases."

Cancer Pain - "Management of Cancer Pain."

Cancer Vaccines - "GM-CSF as a Systemic Adjuvant in a Phase II Prostate Cancer Vaccine Trial."

Hormone Replacement Therapy - "A Mouse Model to Study the Effects of Hormone Replacement Therapy on Normal Mammary Gland During Menopause: Enhanced Proliferative Response To Estrogen in Late Postmenopausal Mice."

Intracranial Gliomas - "Treatment of Intracranial Gliomas With Bone Marrow-Derived Dendritic Cells Pulsed With Tumor Antigens."

Liposomes - "Safety and Efficacy Studies of Liposomes in Specific Immunotherapy."

Melanoma - "Phase II Trial of Biochemotherapy With Interferon alpha, Dacarbazine, Cisplatin and Tamoxifen in Metastatic Melanoma: A Southwest Oncology Group Trial."

Return to Top of Page

NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook